Nebivolol Hydrochloride/Valsartan

盐酸奈必洛尔/缬沙坦

Report date: 2022/01/14 13:23:58

Base Information

Drug NameNebivolol Hydrochloride/Valsartan
Drug Alias Name奈必洛尔缬沙坦Nebivolol Hydrochloride and Valsartan缬沙坦盐酸奈必洛尔Nebivolol/Valsartannebivolol and valsartan +[10] 
ClassificationSmall molecules
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsBeta-1 adrenergic receptor antagonists
TargetsAngiotensin II Receptor Type 1Beta-1 adrenergic receptor
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2016/06/03
Country/TerritoryUnited States
CombinationsYes Nebivolol HydrochlorideValsartan
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesAllergan Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity At BuffaloAbbvie IncForest Laboratories Inc
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeC09DX05
Related LinksN/A